The rising prevalence of diabetes entails a greater need for treatment and monitoring. In this context, multiple growth opportunities arise in the continuous glucose monitoring (CGM) solutions sector. CGM devices have been extensively used for Type 1 diabetes patients. With further technological development and clinical studies, CGM’s applications expand toward Type 2 diabetes, prediabetes, weight management, nutrition tracking, and metabolic health tracking.
• What factors contribute to the low adoption of CGM devices in Asia-Pacific, Latin America, the Middle East, and Africa?
• What patient populations could benefit from the expansion of CGM applications beyond Type 1 diabetes?
• Why do most Type 1 diabetes patients not use CGM solutions?
Sign up for a complimentary Growth Pipeline Dialog™
A Growth Pipeline Dialog is a structured open discussion with our growth experts providing unparalleled industry intelligence, technology advancements, and proven implementation best practices. This discussion will spark innovative thinking and help generate a pipeline of growth opportunities you can leverage to maximize your company’s future growth potential.
